AireHealth, an Orlando-based digital health company, announced it has reached an agreement to acquire BreathResearch, a respiratory healthcare company that detects increasing declines in respiratory health status. Financial terms were not disclosed. for an undisclosed amount. AireHealth will consolidate BreathResearch’s employees and intellectual property, expanding its footprint into the digital therapeutics space. The combined organization will develop the industry’s first complete virtual care platform for respiratory illness to reduce costs and improve outcomes.
This acquisition allows AireHealth to complement its existing portable nebulizer through digital respiratory health care services to complement its existing portable nebulizer. The VitalBreath virtual care platform will empower patients, caregivers, and clinicians to be more informed and collaborative in respiratory care, enabling faster response to exacerbations and translating to fewer emergencies and fewer hospitalizations.
We decided that our plan was to accelerate the AireHealth journey into respiratory digital therapeutics by acquiring a company that will help us save lungs and lives, and that company is BreathResearch. – Stacie Ruth, CEO AireHealth
BreathRearsch’s founder, Nirinjan Yee, will become AireHealth’s Head of Innovation.
AireHealth’s virtual care platform, VitalBreath, provides early detection of respiratory decline. Full visibility to the therapy cycle is created by combining drug adherence and patient engagement with connected drug delivery, connected respiratory devices, and patient-centric companion applications. AireHealth uses 35 proprietary and IP protected biomarkers to look at different dimensions of lung health and processes them in our AI engine to categorize symptom severity. Then the VitalBreath solution detects and calls attention to anomalies and manages respiratory care.
Respiratory illness is a big and growing problem—the number of respiratory compromised people in the United States alone tops 100 million. Helping achieve the quadruple aim, VitalBreath powered by BreathResearch will provide value-based care and early detection of respiratory decline, saving patients’ lungs and lives.
VitalBreath powered by BreathResearch will be able to detect anomalies and manage respiratory health by providing personalized, proactive respiratory care for people with compromised lungs so the patient, caregivers, and clinicians are informed and involved.
AireHealth is an innovative digital health company empowering and improving healthy living through affordable treatments, symptom tracking, and early detection of respiratory conditions. With strong IP and clinically validated products in its pipeline, the company enables more proactive care and early interventions to improve outcomes and reduce costs.
The company provides monitored drug delivery via its FDA cleared Class 2 portable nebulizer, designed to deliver medicine directly to a patient’s lungs where it is most effective. AireHealth’s virtual care platform, VitalBreath powered by BreathResearch, allows for early detection of respiratory decline with the addition of respiratory testing and vital signs. The result is that patients not only take a more proactive approach to manage their respiratory care but a faster response to exacerbations, fewer emergencies, and fewer hospitalizations, which helps achieve their goal of improving treatment outcomes and lowering costs. For more information, please visit Aire.Health.
is was an innovative healthcare company with a mission to improve healthy living through affordable tracking and early detection of respiratory ailments and diseases. BreathResearch’s respiratory research has resulted in the authoring of seven innovative patents and has allowed it to develop a modern portable spirometer. By converting the airwaves from a person’s breath into sound waves in conjunction with measuring lung flow volumes, BreathResearch has the ability to leverage acoustic analytics and artificial intelligence coupled with machine learning to provide profound data insights to detect anomalies and manage respiratory health. BreathResearch’s solution can be either standalone or integrated into other respiratory devices and equipment, allowing considerable versatility with regard to how healthcare professionals and providers leverage the data.